Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Rifaquizinone by TenNor Therapeutics for Irritable Bowel Syndrome: Likelihood of Approval
Rifaquizinone is under clinical development by TenNor Therapeutics and currently in Phase I for Irritable Bowel Syndrome. According to GlobalData,...
Data Insights
Rifaquizinone by TenNor Therapeutics for Skin And Skin Structure Infections (SSSI): Likelihood of Approval
Rifaquizinone is under clinical development by TenNor Therapeutics and currently in Phase III for Skin And Skin Structure Infections (SSSI)....